ACS Nano 2015-08-25

Post-Translational Modification of Bionanoparticles as a Modular Platform for Biosensor Assembly.

Qing Sun, Qi Chen, Daniel Blackstock, Wilfred Chen

Index: ACS Nano 9 , 8554-61, (2015)

Full Text: HTML

Abstract

Context driven biosensor assembly with modular targeting and detection moieties is gaining significant attentions. Although protein-based nanoparticles have emerged as an excellent platform for biosensor assembly, current strategies of decorating bionanoparticles with targeting and detection moieties often suffer from unfavorable spacing and orientation as well as bionanoparticle aggregation. Herein, we report a highly modular post-translational modification approach for biosensor assembly based on sortase A-mediated ligation. This approach enables the simultaneous modifications of the Bacillus stearothermophilus E2 nanoparticles with different functional moieties for antibody, enzyme, DNA aptamer, and dye decoration. The resulting easy-purification platform offers a high degree of targeting and detection modularity with signal amplification. This flexibility is demonstrated for the detection of both immobilized antigens and cancer cells.


Related Compounds

  • SodiuM bicarbonat...
  • L-Glutamine
  • chlorohexane

Related Articles:

Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.

2015-01-01

[Drug Des. Devel. Ther. 9 , 1555-84, (2015)]

Calcium entry via connexin hemichannels in lens epithelium.

2015-03-01

[Exp. Eye Res. 132 , 52-8, (2015)]

H4 histamine receptors inhibit steroidogenesis and proliferation in Leydig cells.

2014-12-01

[J. Endocrinol. 223(3) , 241-53, (2014)]

An integrated biological approach to guide the development of metal-chelating inhibitors of influenza virus PA endonuclease.

2015-02-01

[Mol. Pharmacol. 87(2) , 323-37, (2015)]

Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells.

2015-01-01

[PLoS ONE 10(4) , e0122333, (2015)]

More Articles...